Biocon Ltd. — Regulatory Filings 2021

Jan 5, 2021

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

January 5, 2021

To,	To,
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street,Mumbai – 400 001	Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - Biocon

Subject: Intimation for the Board Meeting and Trading Window Closure

Dear Sir/Madam,

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, January 21, 2021, inter alia, to approve and take on record the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2020 amongst other routine matters.

The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading (‘the Code’) of the Company, has been closed from January 1, 2021 to January 23, 2021 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations.

The above mentioned information will also be available on website of the Company at www.biocon.com.

Request you to take the above intimation on record.

Thanking You,

For Biocon Limited

==> picture [97 x 37] intentionally omitted <==

---

==> picture [77 x 81] intentionally omitted <==

Mayank Verma

Company Secretary and Compliance Officer